Life Sciences Archives - Becker's Hospital Review

Glenmark recalls 24 US drugs | Eli Lilly to make weight loss pill in US | FDA layoffs stall drug development | DOGE's access to HHS

April 23, 2025 BHR Newsletter 1. Eli Lilly to make weight loss pill in US Full story 2. Glenmark recalls 24 US drugs: 4 notes Full story 3. DOGE has access to 19 HHS systems: Report Full story 4. Rising…

Tariffs endanger heparin supply | Pfizer drops GLP-1 drug | FDA to replace animal drug testing | The new norm in diabetes care

April 16, 2025 BHR Newsletter 1. Pfizer discontinues GLP-1 weight loss drug Full story 2. Tariffs may threaten lifesaving heparin supply Full story 3. CivicaScript to offer discounted droxidopa Full story 4. Multidisciplinary excellence: Learn how Fox Chase Cancer Center…

FDA plans fewer drug inspections | Mounjaro beats out Trulicity in study | Shingles vaccine cuts dementia risk | Potential barriers to Elevidys

April 9, 2025 BHR Newsletter 1. After patient’s death, study cites potential barrier to Elevidys Full story 2. Mounjaro outperforms Trulicity in glucose control, weight loss: Study Full story 3. Medicare will not cover GLP-1s for weight loss: 3 notes…

Eli Lilly deepens direct-to-consumer strategy | Ovarian cancer drug, study says | Rybelsus lowers cardiovascular risk in trial | Mount Sinai launches AI center | 6 GLP-1 updates

April 2, 2025 BHR Newsletter 1. Study finds new drug effective against treatment-resistant ovarian cancer Full story 2. Eli Lilly moves to expand Zepbound access Full story 3. Mount Sinai launches new AI center Full story 4. AI and claim…

New therapy delays Alzheimer's | Novo Nordisk buys weight loss drug for $2B | Drug shortages may jump 25% | Medicaid cuts threaten 477K healthcare jobs

March 26, 2025 BHR Newsletter 1. Novo Nordisk to pay up to $2B for experimental weight loss drug Full story 2. Anti-amyloid therapy shows promise in delaying Alzheimer's in at-risk patients Full story 3. Medicaid cuts could cost 477,000 healthcare…

1st death in muscular dystrophy treatment | HIV drug gives yearlong protection | New stroke drug tests favorable | Ozempic may help with aging

March 19, 2025 BHR Newsletter 1. Zepbound, Wegovy fail to justify prices: Study Full story 2. 1st patient death in muscular dystrophy treatment Full story 3. HIV drug could offer yearlong protection with a single shot Full story 4. Baptist…

Common drug may slow cancer spread | Drugmaker called out for false claims | Teladoc, Eli Lilly team up | 1.5M bottles of ADHD drug recalled

March 12, 2025 BHR Newsletter 1. FDA scolds drugmaker for 'false or misleading' claims Full story 2. The common drug that may prevent cancer spread Full story 3. Novo Nordisk drug yields 15.7% weight loss in phase 3 trial Full…

Malaria drug reused for cancer | FDA sued over semaglutide ruling | Eli Lilly debuts new Zepbound vials | Breast cancer drug shows promise

March 5, 2025 BHR Newsletter 1. Eli Lilly unveils high-dose, low-cost Zepbound vials Full story 2. Texas researchers repurpose malaria drug for cancer Full story 3. Growing insurer restrictions limit GLP-1 coverage: GoodRx Full story 4. Downtime costs more than…

Generic cancer drug approved | Merck jury trial delayed | Trump revisits healthcare price transparency | Vaccines for pancreatic cancer show promise

February 26, 2025 BHR Newsletter 1. Jury trial over Merck vaccine delayed Full story 2. FDA approves generic cancer treatment for 2026 availability Full story 3. Trump revisits price transparency with new executive order: 5 things to know Full story…

FDA OKs 1st rapid-acting insulin biosimilar | 4 federal healthcare updates | HHS to probe pediatric medicines | 24 drugmakers among best employers

February 19, 2025 BHR Newsletter 1. FDA OKs 1st rapid-acting insulin biosimilar Full story 2. Pfizer and Astellas drug combo doubled survival in bladder cancer patients: Study Full story 3. DOGE clears legal hurdle; Trump signs IVF order: 4 federal…

Stay Informed with Becker’s Hospital Review Newsletter